Oncode Institute

𝐒𝐢𝐱 𝐎𝐧𝐜𝐨𝐝𝐞 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫𝐬 𝐒𝐞𝐜𝐮𝐫𝐞 𝐊𝐖𝐅 𝐆𝐫𝐚𝐧𝐭 𝐟𝐨𝐫 𝐆𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡   KWF Kankerbestrijding invests €39 million to finance 35 groundbreaking research projects. We congratulate Michiel Vermeulen, Wilbert Zwart, Daniel Peeper, Thijn Brummelkamp (The Netherlands Cancer Institute), Ruben van Boxtel (Prinses Máxima Centrum voor kinderoncologie) and Jop Kind (Hubrecht Institute, Developmental Biology and Stem Cell Research) with securing a KWF research grant!   To learn more about these exciting projects, click here: https://lnkd.in/eSmSBYMs #CancerResearch #OncodeInstitute #MedicalResearch #Collaboration #Innovation

🎉Celebrating two Oncode Investigator-led  projects receiving NWO-XL funding🎉 Both teams and their projects exemplify what Oncode Institute stands for: collaboration across barriers, boundaries and disciplines, to combat cancer in collaboration: 🌟Sjoerd van der Burg and partners will investigate the role of myeloid cells in the failure or success of immune therapy, continuing on the exciting findings resulting from the collaborative Oncode Synergy Project. 🌟Jurgen Marteijn and partners will study the causes and consequences of transcription problems caused by DNA damage. With Oncode Investigators   👏 We couldn’t be more proud of all the involved investigators and their dedication to advancing knowledge and cracking the code of cancer, together! With Oncode Investigators Michiel Vermeulen, Titia Sixma, Miao-Ping Chien, Tineke Lenstra, Karin de Visser, Sarah Derks, leila akkari & Linde Meyaard as well as Hannes Lans, Nynke Dekker and Jolanda de Vries. 👉 Read more about these and the other awarded projects here: https://lnkd.in/e5zKM6Sy Leiden University Medical Center, Erasmus MC, The Netherlands Cancer Institute, UMC Utrecht, Amsterdam UMC, Radboud University, Radboudumc, Delft University of Technology. NWO (Dutch Research Council)

We proudly congratulate Oncode Investigator Anne Rios, Amber Wezenaar of Prinses Máxima Centrum voor kinderoncologie and our own Saharla Ahmed, on winning the LifeSciences@Work – Venture Challenge with their venture Sniper Therapeutics! “Winning the Venture Challenge is a testament to your unwavering dedication, groundbreaking ideas, and collaborative spirit. Together, you embody the innovation and impact we strive for, turning scientific discovery into real-world impact. This achievement is not just a milestone but a launchpad for even greater success. Congratulations on this well-deserved recognition!" Read more about their winning innovation and ambition here: https://lnkd.in/g9V8Fe6J

🎯 𝐖𝐡𝐚𝐭 𝐜𝐚𝐧 𝐬𝐢𝐧𝐠𝐥𝐞-𝐜𝐞𝐥𝐥 𝐩𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜𝐬 𝐭𝐞𝐚𝐜𝐡 𝐮𝐬 𝐚𝐛𝐨𝐮𝐭 𝐭𝐮𝐦𝐨𝐫𝐢𝐠𝐞𝐧𝐞𝐬𝐢𝐬 𝐚𝐧𝐝 𝐢𝐦𝐦𝐮𝐧𝐞 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲?   Join organizers and experts Michiel Vermeulen (Oncode Institute/Radboud University & NKI) and Harmjan Vos (Oncode Institute/UMC Utrecht) for an immersive masterclass, featuring leading speakers such as Sebastiaan van Heesch (Prinses Máxima Centrum voor kinderoncologie), Erwin M. Schoof (DTU - Technical University of Denmark), Jeroen Krijgsveld (Krebsinformationsdienst, Deutsches Krebsforschungszentrum), and Jeroen Demmers (Erasmus MC).   🧬 Includes a tour of the UMC Utrecht proteomics facility!   📅 When: January 30, 2025 📍 Where: UMC Utrecht, Stratenum Building 🔗 Register here: https://lnkd.in/eV9VXm4K

🌟Oncode Investigator Sjoerd van der Burg and team @Leiden University Medical Center dive into the role of myeloid effector cells in cancer. 💡 In their comprehensive perspective article, they describe how these cells contribute to tumor control during successful immunotherapy, how they interact with tumor-specific T cells, and discuss strategies to activate them for therapeutic applications. 👉 Read the full article in Cancer Cell by Cell Press: https://lnkd.in/gu_GkskT 🔬  Don’t hesitate to also read about the latest findings from the van der Burg Group, by Marit van Elsas and Jim Middelburg et al, describing a critical interplay between T cells and macrophages in achieving robust anti-tumor immunity. 📜 Read the full story in Cancer Cell by Cell Press here:  https://lnkd.in/gTxiWsb5  

📣 New Research Alert! 📣 ✨ Research led by Oncode Investigator Jacco van Rheenen at The Netherlands Cancer Institute in collaboration with Colinda Scheele at VIB-KU Leuven Center for Cancer Biology shows that the menstrual cycle phase may influence the effectiveness of chemotherapy in breast cancer. 💡This finding highlights the importance of further research into the menstrual cycle, the effects of drugs on women versus men, and female-specific research in general. The results are out now in Nature, read more here 👇 https://lnkd.in/gr8_J84i

𝗢𝗻𝗰𝗼𝗱𝗲 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲, 𝗢𝗻𝗰𝗼𝗱𝗲 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗛𝗼𝗿𝗶𝘇𝗼𝗻𝘀 𝗳𝗼𝗿𝗺 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗮𝗹𝗹𝗶𝗮𝗻𝗰𝗲 𝗱𝘂𝗿𝗶𝗻𝗴 𝗗𝘂𝘁𝗰𝗵 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 We are excited to announce that during this week's Dutch Economic Mission to the United Kingdom led by the Netherlands Enterprise Agency (RVO), The Dutch Ministerie van Buitenlandse Zaken, and the Dutch embassy in London, Oncode Institute,  Oncode Accelerator, and Cancer Research Horizons – the innovation arm of Cancer Research UK (CRUK) – took an important step towards future collaboration. “Jan Paul Medema, our Scientific Director and Head of Oncode Institute: “Together we are stronger: with the vast pool of oncology expertise embodied by the partner’s commitment to building and funding innovations that accelerate the development of novel cancer therapies, we can further accelerate the translation of scientific breakthroughs to tangible solutions that benefit patients. This brings us closer to outsmarting cancer and impacting lives on an international scale.” Read the whole story here 👇 https://lnkd.in/gnSxkVx7 #OutsmartingCancer | #ImpactingLives Photo credits: pdmedia (https://lnkd.in/g9rEc3Qq)

We are very proud to announce that Oncode Investigator Sylvie Noordermeer at Leiden University Medical Center was selected to become an EMBO Young Investigator! Congratulations with this well-deserved recognition Sylvie! EMBO is an organization of leading researchers that promotes excellence in the life sciences in Europe and beyond. With this appointment Sylvie will become part of an international network of nearly 800 talented researchers, and gain access to a broad range of support to further advance her career and drive her groundbreaking science. 

We proudly congratulate three of our Oncode Investigators for being awarded an ERC-Consolidator Grant! Miao-Ping Chien at Erasmus MC, Tineke Lenstra at The Netherlands Cancer Institute and Jarno Drost at Prinses Máxima Centrum voor kinderoncologie will receive this prestigious grant from the European Research Council (ERC) to further drive their innovative cancer research. Jan Paul Medema, Scientific Director and Head of Oncode Institute: “This ERC grant is a testament to these talented researchers’ groundbreaking work. We are proud to call them Oncode Investigators and look forward to the impactful insights that will no doubt result from their research in the coming years.”

Congratulations to Oncode Investigator Jeroen de Ridder of UMC Utrecht for winning the Dutch Applied AI Award ! We're proud to see the Sturgeon technology result in impact for patients already! #outsmartingcancer, #impactinglives